Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
The treatment paradigm in renal cell carcinoma (RCC) is rapidly changing. The incidental finding of small renal tumours combined with the development of novel therapeutic agents targeting the vascular endothelial growth factor (VEGF) or the mammalian target of rapamycin (mTOR) pathways or inhibiting...
Main Authors: | Kyriazoglou Anastasios, Dimitriadis Ioannis, Bamias Aristotelis |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-06-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1515/fco-2015-0025 |
Similar Items
-
Management of metastatic renal cell carcinoma – mini review
by: Anubha Bharthuar, et al.
Published: (2015-05-01) -
Role of metastasectomy in the management of renal cell carcinoma
by: Mark Mikhail, et al.
Published: (2022-07-01) -
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
by: Soichi Matsumura, et al.
Published: (2023-06-01) -
Metastatic Clear-Cell Renal Carcinoma: An Exceptional Cause of Ileocolonic Intussusception in Adults
by: Francisco E. Alvarez-Bautista, et al.
Published: (2023-06-01) -
Metastatic Renal Cell Carcinoma in the Sinonasal Region
by: Jyothi A Raj, et al.
Published: (2013-08-01)